| Literature DB >> 34949227 |
Navneet Kaur1,2, Vijaya Majumdar3, Raghuram Nagarathna4, Neeru Malik5, Akshay Anand6, Hongasandra Ramarao Nagendra3.
Abstract
PURPOSE: To study the effectiveness of diabetic yoga protocol (DYP) against management of cardiovascular risk profile in a high-risk community for diabetes, from Chandigarh, India.Entities:
Keywords: Diabetes; Diabetic yoga protocol; Glycated hemoglobin; Indian diabetes risk score; Prediabetes
Year: 2021 PMID: 34949227 PMCID: PMC8696241 DOI: 10.1186/s13098-021-00761-1
Source DB: PubMed Journal: Diabetol Metab Syndr ISSN: 1758-5996 Impact factor: 3.320
Fig. 1Flowchart of study design. PCA principal component analysis, MIPCA multiple imputations with PCA
Diabetic yoga protocol (DYP)
| S. No. | Name of practice | Duration (min) |
|---|---|---|
| 1 | Starting prayer: Asatoma Sat Gamaya | 2 |
| 2 | Preparatory Sukshma Vyayamas and Shithililarna Practices 1. 2. 3. Sarvangapushti (3 rounds clockwise, 3 rounds anticlockwise) | 6 |
| 3 | Surya Namaskara (SN) 10 step fast 12 step slow Modified version Chair SN 7 rounds | 9 |
| 4 | Asanas (1 min per Asana) 1 Trikonasana, Parvritta Trikonasana, Prasarita Padhastasana 2 Jatara Parivartanasana, Pawanmuktasana, Viparitakarani 3 Bhujangasana, Dharuasana followed by Pawanmuktasana 4 Mandukasana, Vakrasana/ Ardhamatsayendrasana, Paschimatanasana, Ardha Ushtrasana At the end, relaxation with abdominal breathing in supine position (vishranti), 10–15 rounds (2 min) | 15 |
| 5 | Kriya a. | 3 |
| 6 | Pranayama | 9 |
| 7 | Meditation (for Stress, for deep relaxation and silencing of mind) Cyclic Meditation | 15 |
| 8 | Resolve (I am Completely Healthy) | 1 |
| 9 | Closing Prayer: Sarvebhavantu Sukhina………… | 1 |
| Total duration | 60 |
Baseline characteristics of the participants in the intervention and control group
| Characteristics | DYP Group | Control group | P value |
|---|---|---|---|
| Gender | |||
| Male, n (%) | 19 (20.88) | 30 (32.26) | 0.096 |
| Age (years) | 47.77 (9.59) | 49.24 (10.53) | 0.323 |
| Weight, Kg | 70.93 (10.90) | 70.80 (12.44) | 0.936 |
| Waist circumference, cm | 99.34 (9.05) | 99.72 (9.05) | 0.794 |
| BMI, Kg/m2 | 28.59 (5.75) | 28.53 (5.01) | 0.949 |
| IDRS | 74.07 (10.43) | 75.27 (9.95) | 0.425 |
| Biochemical variables | |||
| FBG, mg/dl | 96.89 (9.95) | 97.36 (12.20) | 0.776 |
| PPBG, mg/dl | 102.88 (21.91) | 113.78 (33.47) | 0.012* |
| HbA1c (%) | 5.61 (0.38) | 5.66 (0.38) | 0.400 |
| Total cholesterol mg/dl | 186.88 (37.64) | 179.98 (34.98) | 0.199 |
| Triglycerides, mg/dl | 131.93 (68.59) | 138.44 (68.89) | 0.522 |
| HDL-c, mg/dl | 47.76 (9.16) | 48.33 (17.43) | 0.780 |
| LDL-c, mg/dl | 112.75 (31.02) | 104.38 (31.70) | 0.072 |
| VLDL, mg/dl | 26.39 (13.72) | 28.00 (13.50) | 0.423 |
Continuous variables are represented as mean (SD) and compared using independent t-test. Categorical variables are represented as number (percentages) and compared using chi-square test. P value < 0.05 were considered significant. FBS fasting blood sugar, PPBG postprandial blood glucose, HbA1c glycated hemoglobin, HDL-c high density lipid-cholesterol, LDL-c low density lipid-cholesterol, VLDL very low density lipid-cholesterol, IDRS Indian diabetes risk score
Comparative assessment of influence of DYP on biochemical and weight related variables with the control group
| Variables | Baseline | After 3 months | Absolute | Relative change | P value | Partial η2 |
|---|---|---|---|---|---|---|
| Waist circumference (cm) | ||||||
| DYP | 99.34 (9.05) | 98.14 (6.88) | − 1.93 | − 1.94 | 0.032 | 0.029 |
| Control | 99.72 (9.05) | 100.25 (7.72) | ||||
| BMI, kg/m2 | ||||||
| DYP | 28.59 (5.75) | 28.00 (6.84) | − 0.4 | − 1.40 | 0.622 | 0.002 |
| Control | 28.53 (5.01) | 28.34 (4.98) | ||||
| Weight, Kg | ||||||
| DYP | 70.93 (10.90) | 69.04 (9.13) | − 1.04 | − 1.47 | 0.397 | 0.005 |
| Control | 70.80 (12.44) | 69.95 (10.44) | ||||
| Postprandial blood glucose, mg/dl | ||||||
| DYP | 102.88 (21.91) | 118.32 (29.89) | − 1.51 | − 1.47 | 0.006 | 0.046 |
| Control | 113.78 (33.47) | 130.73 (36.98) | ||||
| Fasting blood glucose, mg/dl | ||||||
| DYP | 96.89 (9.95) | 99.82 (9.49) | 1.44 | 1.49 | 0.287 | 0.007 |
| Control | 97.36 (12.20) | 98.85 (9.26) | ||||
| HBA1c (%) | ||||||
| DYP | 5.61 (0.38) | 5.61 (0.39) | − 0.02 | − 0.36 | 0.077 | 0.020 |
| Control | 5.66 (0.38) | 5.68 (0.38) | ||||
| Total Cholesterol, mg/dl | ||||||
| DYP | 186.88(37.64) | 189.01 (25.64) | − 0.4 | − 0.21 | 0.130 | 0.014 |
| Control | 179.98 (34.98) | 182.51(20.82) | ||||
| Triglycerides, TG, mg/dl | ||||||
| DYP | 131.93 (68.59) | 148.14 (54.92) | − 13.98 | − 10.60 | 0.138 | 0.014 |
| Control | 138.44 (68.89) | 168.63 (75.06) | ||||
| HDL-C, mg/dl | ||||||
| DYP | 47.76 (9.16) | 47.01 (9.16) | 2.2 | 4.61 | 0.097 | 0.017 |
| Control | 48.33 (17.43) | 45.38 (12.57) | ||||
| LDL-C, mg/dl | ||||||
| DYP | 112.75 (31.02) | 103.39 (21.44) | − 17.56 | − 15.57 | 0.044* | 0.025 |
| Control | 104.38 (31.70) | 112.58 (21.99) | ||||
| VLDL, mg/dl | ||||||
| DYP | 26.39 (13.72) | 28.85 (10.47) | − 1.23 | − 4.66 | 0.229 | 0.009 |
| Control | 28.00 (13.50) | 31.69 (10.57) |
Absolute change = [(intervention group follow-up) – (intervention group baseline)] – [(control group follow-up) – (control group baseline)]. Relative change = (absolute change / intervention group baseline) × 100%; p value for difference between the intervention and the control groups by MANCOVA adjusting for age, gender, status of diabetes/prediabetes/normoglycemia baseline values of glycemic and lipid variables, length of time having had prior exposure of yoga